SCHEMBL26084833

SCHEMBL26084833

CC(=O)Oc1ccc(CSI)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.52
▸ MAPT P10636 3/20 0.47
▸ POLB P06746 2/20 0.47
▸ PKM P14618 1/20 0.47
▸ ELANE P08246 2/20 0.46
▸ HSD17B10 Q99714 2/20 0.44
▸ ESR1 P03372 1/20 0.44
▸ PGR P06401 1/20 0.44
▸ CHRM2 P08172 1/20 0.44
▸ ADORA3 P0DMS8 1/20 0.44
▸ AR P10275 1/20 0.44
▸ CHRM1 P11229 1/20 0.44
▸ SLC6A2 P23975 1/20 0.44
▸ SLC6A3 Q01959 1/20 0.44
▸ GAA P10253 2/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ HSP90AA1 P07900 1/20 0.43
▸ KMT2A Q03164 4/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ MEN1 O00255 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6031811 0.85 LMNA (0.55) LMNAMAPTPOLBPKMELANE
SCHEMBL14139588 0.83 LMNA (0.53) LMNAMAPTPOLBPKMELANE
SCHEMBL19514710 0.81 LMNA (0.52) LMNAMAPTPOLBPKMELANE
SCHEMBL14611612 0.81 LMNA (0.52) LMNAMAPTPOLBPKMELANE
SCHEMBL95878 0.80 LMNA (0.59) LMNAMAPTPOLBPKMELANE
SCHEMBL26079068 0.80 CYP3A4 (0.53) LMNAKMT2AMEN1CYP3A4
SCHEMBL26908219 0.79 HSD17B10 (0.54) LMNAMAPTPOLBPKMELANE
SCHEMBL28973261 0.79 ELANE (0.56) LMNAMAPTPOLBPKMELANE
SCHEMBL14389508 0.79 LMNA (0.48) LMNAMAPTPOLBPKMELANE
SCHEMBL1013508 0.79 LMNA (0.57) LMNAMAPTPOLBPKMELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230314938-A1 CARBOXYLATE, CARBOXYLIC ACID GENERATOR, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-10-05 — — US disclosed
US-20230305395-A1 SALT, ACID GENERATOR, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-09-28 — — US disclosed
US-20230305391-A1 SALT, ACID GENERATOR, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230305391-A1 SALT, ACID GENERATOR, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN RER1, H1-0, BET1 LMNA 2852/4885MAPT 3864/4885POLB 790/4885
US-20230314938-A1 CARBOXYLATE, CARBOXYLIC ACID GENERATOR, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN HCAR1, H1-0, H1-10 LMNA 4546/4885MAPT 4708/4885POLB 186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback